Tactile Systems Technology (TCMD) Competitors

$23.29 -0.24 (-1.02%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$23.00 -0.29 (-1.22%)

As of 05/13/2026 05:36 PM Eastern

TCMD vs. ESTA, NVCR, EYE, AORT, and PRCT

Should you buy Tactile Systems Technology stock or one of its competitors? MarketBeat compares Tactile Systems Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tactile Systems Technology include Establishment Labs (ESTA), NovoCure (NVCR), National Vision (EYE), Artivion (AORT), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

How does Tactile Systems Technology compare to Establishment Labs?

Tactile Systems Technology (NASDAQ:TCMD) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

Tactile Systems Technology has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

Tactile Systems Technology has a net margin of 5.91% compared to Establishment Labs' net margin of -19.05%. Tactile Systems Technology's return on equity of 9.70% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Establishment Labs	-19.05%	-218.77%	-12.31%

Tactile Systems Technology has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.59	$19.09M	$0.88	26.47
Establishment Labs	$211.08M	9.63	-$51.06M	-$1.49	N/A

In the previous week, Establishment Labs had 1 more articles in the media than Tactile Systems Technology. MarketBeat recorded 10 mentions for Establishment Labs and 9 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.68 beat Establishment Labs' score of 0.34 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 10.0% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Tactile Systems Technology currently has a consensus target price of $38.60, suggesting a potential upside of 65.74%. Establishment Labs has a consensus target price of $87.14, suggesting a potential upside of 26.15%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, equities research analysts plainly believe Tactile Systems Technology is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

Summary

Tactile Systems Technology beats Establishment Labs on 12 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to NovoCure?

Tactile Systems Technology (NASDAQ:TCMD) and NovoCure (NASDAQ:NVCR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

Tactile Systems Technology has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

Tactile Systems Technology has a net margin of 5.91% compared to NovoCure's net margin of -25.66%. Tactile Systems Technology's return on equity of 9.70% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
NovoCure	-25.66%	-50.82%	-16.48%

Tactile Systems Technology has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.59	$19.09M	$0.88	26.47
NovoCure	$655.35M	3.20	-$136.23M	-$1.53	N/A

In the previous week, Tactile Systems Technology had 7 more articles in the media than NovoCure. MarketBeat recorded 9 mentions for Tactile Systems Technology and 2 mentions for NovoCure. NovoCure's average media sentiment score of 1.67 beat Tactile Systems Technology's score of 0.68 indicating that NovoCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NovoCure	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 84.6% of NovoCure shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 5.5% of NovoCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Tactile Systems Technology currently has a consensus target price of $38.60, suggesting a potential upside of 65.74%. NovoCure has a consensus target price of $27.29, suggesting a potential upside of 50.75%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, equities research analysts plainly believe Tactile Systems Technology is more favorable than NovoCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
NovoCure	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Tactile Systems Technology beats NovoCure on 10 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to National Vision?

National Vision (NASDAQ:EYE) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

83.4% of Tactile Systems Technology shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

National Vision has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

In the previous week, National Vision had 4 more articles in the media than Tactile Systems Technology. MarketBeat recorded 13 mentions for National Vision and 9 mentions for Tactile Systems Technology. National Vision's average media sentiment score of 1.07 beat Tactile Systems Technology's score of 0.68 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision presently has a consensus target price of $32.08, suggesting a potential upside of 89.58%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 65.74%. Given National Vision's higher possible upside, equities analysts plainly believe National Vision is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

National Vision has higher revenue and earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.68	$29.60M	$0.37	45.73
Tactile Systems Technology	$329.52M	1.59	$19.09M	$0.88	26.47

Tactile Systems Technology has a net margin of 5.91% compared to National Vision's net margin of 1.49%. Tactile Systems Technology's return on equity of 9.70% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	1.49%	5.15%	2.22%
Tactile Systems Technology	5.91%	9.70%	7.53%

Summary

National Vision beats Tactile Systems Technology on 9 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to Artivion?

Artivion (NYSE:AORT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Artivion had 14 more articles in the media than Tactile Systems Technology. MarketBeat recorded 23 mentions for Artivion and 9 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.68 beat Artivion's score of 0.14 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	2 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tactile Systems Technology	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has a net margin of 5.91% compared to Artivion's net margin of 2.55%. Tactile Systems Technology's return on equity of 9.70% beat Artivion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
Tactile Systems Technology	5.91%	9.70%	7.53%

Artivion currently has a consensus price target of $47.83, suggesting a potential upside of 115.13%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 65.74%. Given Artivion's stronger consensus rating and higher probable upside, equities analysts clearly believe Artivion is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

86.4% of Artivion shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 6.3% of Artivion shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tactile Systems Technology has lower revenue, but higher earnings than Artivion. Tactile Systems Technology is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.45	$9.77M	$0.24	92.65
Tactile Systems Technology	$329.52M	1.59	$19.09M	$0.88	26.47

Artivion has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Summary

Artivion beats Tactile Systems Technology on 10 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to PROCEPT BioRobotics?

PROCEPT BioRobotics (NASDAQ:PRCT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

PROCEPT BioRobotics has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Tactile Systems Technology has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	4.75	-$95.57M	-$1.82	N/A
Tactile Systems Technology	$329.52M	1.59	$19.09M	$0.88	26.47

Tactile Systems Technology has a net margin of 5.91% compared to PROCEPT BioRobotics' net margin of -31.82%. Tactile Systems Technology's return on equity of 9.70% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-31.82%	-27.70%	-20.29%
Tactile Systems Technology	5.91%	9.70%	7.53%

PROCEPT BioRobotics currently has a consensus price target of $41.45, suggesting a potential upside of 61.30%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 65.74%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.43
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, Tactile Systems Technology had 1 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 9 mentions for Tactile Systems Technology and 8 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.12 beat Tactile Systems Technology's score of 0.68 indicating that PROCEPT BioRobotics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 6.6% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Tactile Systems Technology beats PROCEPT BioRobotics on 11 of the 17 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TCMD vs. The Competition

Export

Metric	Tactile Systems Technology	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$530.75M	$6.90B	$6.30B	$12.20B
Dividend Yield	N/A	1.72%	2.79%	5.30%
P/E Ratio	26.47	49.93	21.03	25.58
Price / Sales	1.59	39.65	552.98	78.84
Price / Cash	20.43	24.21	42.94	55.34
Price / Book	2.41	6.49	9.82	6.66
Net Income	$19.09M	$158.34M	$3.55B	$333.63M
7 Day Performance	-10.46%	-1.83%	-0.53%	-0.11%
1 Month Performance	-7.06%	-1.10%	1.20%	3.94%
1 Year Performance	143.11%	-2.35%	41.23%	36.07%

Tactile Systems Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TCMD Tactile Systems Technology	4.2468 of 5 stars	$23.29 -1.0%	$38.60 +65.7%	+135.7%	$530.75M	$329.52M	26.47	1,086	Insider Trade
ESTA Establishment Labs	3.4806 of 5 stars	$71.44 +1.7%	$86.86 +21.6%	+97.6%	$2.10B	$211.08M	N/A	1,004	Earnings Report
NVCR NovoCure	3.8461 of 5 stars	$16.05 -5.2%	$27.29 +70.0%	-0.2%	$1.86B	$674.41M	N/A	1,605	Positive News
EYE National Vision	4.334 of 5 stars	$22.24 +1.5%	$31.21 +40.4%	-10.3%	$1.77B	$1.99B	60.09	13,138	Trending News Earnings Report Gap Down
AORT Artivion	4.2309 of 5 stars	$35.30 -0.7%	$51.00 +44.5%	-23.1%	$1.71B	$441.33M	176.53	1,800

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TCMD) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tactile Systems Technology (TCMD) Competitors

TCMD vs. ESTA, NVCR, EYE, AORT, and PRCT

How does Tactile Systems Technology compare to Establishment Labs?

Summary

How does Tactile Systems Technology compare to NovoCure?

Summary

How does Tactile Systems Technology compare to National Vision?

Summary

How does Tactile Systems Technology compare to Artivion?

Summary

How does Tactile Systems Technology compare to PROCEPT BioRobotics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tactile Systems Technology (TCMD) Competitors

TCMD vs. ESTA, NVCR, EYE, AORT, and PRCT

How does Tactile Systems Technology compare to Establishment Labs?

Which has more risk & volatility, TCMD or ESTA?

Is TCMD or ESTA more profitable?

Which has preferable earnings and valuation, TCMD or ESTA?

Does the media refer more to TCMD or ESTA?

Do insiders & institutionals have more ownership in TCMD or ESTA?

Do analysts recommend TCMD or ESTA?

Summary

How does Tactile Systems Technology compare to NovoCure?

Which has more risk & volatility, TCMD or NVCR?

Is TCMD or NVCR more profitable?

Which has preferable earnings and valuation, TCMD or NVCR?

Does the media refer more to TCMD or NVCR?

Do insiders & institutionals have more ownership in TCMD or NVCR?

Do analysts recommend TCMD or NVCR?

Summary

How does Tactile Systems Technology compare to National Vision?

Do institutionals & insiders hold more shares of EYE or TCMD?

Which has more volatility & risk, EYE or TCMD?

Does the media prefer EYE or TCMD?

Do analysts rate EYE or TCMD?

Which has higher earnings and valuation, EYE or TCMD?

Is EYE or TCMD more profitable?

Summary

How does Tactile Systems Technology compare to Artivion?

Does the media refer more to AORT or TCMD?

Is AORT or TCMD more profitable?

Do analysts prefer AORT or TCMD?

Do insiders and institutionals hold more shares of AORT or TCMD?

Which has preferable earnings and valuation, AORT or TCMD?

Which has more risk and volatility, AORT or TCMD?

Summary

How does Tactile Systems Technology compare to PROCEPT BioRobotics?

Which has more risk and volatility, PRCT or TCMD?

Which has preferable earnings and valuation, PRCT or TCMD?

Is PRCT or TCMD more profitable?

Do analysts prefer PRCT or TCMD?

Does the media refer more to PRCT or TCMD?

Do insiders and institutionals hold more shares of PRCT or TCMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools